Anna Rivkin - 03 Sep 2024 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief Business Officer
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Anna Rivkin
Issuer symbol
FHTX
Transactions as of
03 Sep 2024
Net transactions value
+$1,491,500
Form type
4
Filing time
04 Sep 2024, 16:02:47 UTC
Next filing
24 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHTX Stock Options (Right to buy) Award $1,491,500 +190,000 $7.85 190,000 03 Sep 2024 Common Stock 190,000 $7.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the underlying shares of common stock on September 3, 2025, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until the option is fully vested.